# Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

> **NCT07013370** · — · RECRUITING · sponsor: **Antonello Di Paolo, M.D., Ph.D.** · enrollment: 150 (estimated)

## Conditions studied

- Immunoglobulin Prophylaxis
- Cytomegalovirus Infections
- Allogeneic Hematopoietic Stem Cell Transplantation
- Transplant-Related Disorder

## Interventions

- **BIOLOGICAL:** Anti-CMV immunoglobulins [Megalotect (R)]

## Key facts

- **NCT ID:** NCT07013370
- **Lead sponsor:** Antonello Di Paolo, M.D., Ph.D.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-02
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-02
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07013370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07013370, "Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07013370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*